Source

Journal of Drug Assessment

Homepage: tandfonline.com

ISSNs: 1369-9474, 2155-6660

Source type: journal

Publisher: Taylor & Francis

Alternate name: JDA

Fully OA: No

DOAJ: No

Article Processing Charge: $969

OpenAlex ID: S4210216986

Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials

2020 · Danesh Alam, Carlos Tirado, et al. · Journal of Drug Assessment · 171

Epidemiology of atopic dermatitis in Europe

2019 · Elżbieta Kowalska-Olędzka, Magdalena Czarnecka, et al. · Journal of Drug Assessment · 137

Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates

2019 · Müberra Devrim Güner, Perihan Elif Ekmekci · Journal of Drug Assessment · 109

PDF

Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium

2013 · Paul Colthorpe, Thomas Voshaar, et al. · Journal of Drug Assessment · 75

PDF

2020 · Beatriz Canibaño, Dirk Deleu, et al. · Journal of Drug Assessment · 68

Translation and validation of the English version of the general medication adherence scale (GMAS) in patients with chronic illnesses

2019 · Atta Abbas Naqvi, Mohamed Azmi Hassali, et al. · Journal of Drug Assessment · 63

PDF

Impact of fractures on quality of life in patients with osteoporosis: a US cross-sectional survey

2019 · Deborah T. Gold, Setareh A. Williams, et al. · Journal of Drug Assessment · 57

Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal women

2019 · E. Michael Lewiecki, Deane Leader, et al. · Journal of Drug Assessment · 55

Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteers

2013 · Renli Teng, Kathleen Butler · Journal of Drug Assessment · 49

PDF

A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40–120 mg/day) in patients with major depressive disorder

2014 · Carl P. Gommoll, William M. Greenberg, et al. · Journal of Drug Assessment · 43

Impact of region of diagnosis, ethnicity, age, and gender on survival in acute myeloid leukemia (AML)

2018 · Utkarsh H. Acharya, Anna B. Halpern, et al. · Journal of Drug Assessment · 39

Absolute bioavailability and regional absorption of ticagrelor in healthy volunteers

2014 · Renli Teng, Juan Maya · Journal of Drug Assessment · 39

PDF

Magnitude and associated factors of medication administration error among nurses working in Amhara Region Referral Hospitals, Northwest Ethiopia

2020 · Enyew Getaneh Mekonen, Mignote Hailu Gebrie, et al. · Journal of Drug Assessment · 37

Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews

2022 · Babafemi O. Taiwo, Hela Romdhani, et al. · Journal of Drug Assessment · 36

Economic burden of relapse/recurrence in patients with major depressive disorder

2019 · Genevieve Gauthier, Lisa Mucha, et al. · Journal of Drug Assessment · 35

Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy database

2021 · Zumi Mehta, Khalid M. Kamal, et al. · Journal of Drug Assessment · 34

The accuracy of a non-invasive glucose monitoring device does not depend on clinical characteristics of people with type 2 diabetes mellitus

2018 · Tamar Lin, Yulia Mayzel, et al. · Journal of Drug Assessment · 32

PDF

Use of oral rivaroxaban in cerebral venous thrombosis

2020 · Muhammad Maqsood, Muhammad Imran Hasan Khan, et al. · Journal of Drug Assessment · 31

A review on modafinil: the characteristics, function, and use in critical care

2020 · Seyed MohammadReza Hashemian, Tayebeh Farhadi · Journal of Drug Assessment · 30

PDF

Hereditary angioedema patients would prefer newer-generation oral prophylaxis

2020 · Daniela Geba, Johan Mohd Sani, et al. · Journal of Drug Assessment · 29

Efficacy and safety of PCSK9 monoclonal antibodies: an evidence-based review and update

2020 · Rasha Kaddoura, Bassant Orabi, et al. · Journal of Drug Assessment · 28

Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis

2019 · Aristeidis Skandamis, Chara Kani, et al. · Journal of Drug Assessment · 28

PDF

Autologous conditioned serum: clinical and functional results using a novel disease modifying agent for the management of knee osteoarthritis

2020 · Matteo Vitali, Marco Ometti, et al. · Journal of Drug Assessment · 27

Prevalence of Helicobacter pylori infection and the incidence of the associated malignant and peptic ulcer disease (PUD) at Nelson Mandela Academic Hospital: a retrospective analysis

2021 · Stephen Z. Molaoa · Journal of Drug Assessment · 26

A systematic evidence-based review of treatments for primary hyperhidrosis

2020 · Michael E. Stuart, Sheri A. Strite, et al. · Journal of Drug Assessment · 26

PDF

Works count: 210

Citation count: 2,233

H-index: 26

I10-index: 62

2yr mean citedness: